In 2016, the Jefferson Trust provided the Peirce-Cottler Biomedical Engineering Lab with $60,000 to develop leadership in the field of 3D-bioprinting using UVA’s two cutting-edge bioprinters.
Jefferson Trust trustee Jennings Grant toured the Peirce-Cottler Biomedical Engineering Lab with Ph.D. candidate Molly Kelly-Goss this past week. The research lab now houses two of the most sophisticated 3D-bioprinters in the world. Kelly-Goss explained the profound impact that bio printing will have in future medical innovation and the importance of training the next generation of scientists, engineers and doctors in order to maximize its potential. Areas that the lab’s scientists are currently exploring include the use of 3D bioprinting to create small muscle applications, which may be used to create therapies for muscular injury or diseases such as Duchenne’s Muscular Dystrophy and congenital diaphragmatic hernia. Grant noted, “While visiting the lab, I was able to observe the hard work and research being conducted by the students and professionals at UVA. As I watched the 3D bioprinter in action, I could envision a time when we are able to progress to more complex tissues and eventually organs. At UVA, we have access to state-of-the-art machines…leveraging these assets positions UVA at the forefront of leading edge technology and research in the country.”
Pictured: Molly Kelly-Goss (left) showing trustee Jennings Grant (right) the technology behind 3D-bioprinting.